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Abstract 
 
BACKGROUND: The lack of adjustment for unmeasured factors which may be associated with 
both delivery decisions and pregnancy outcomes has likely resulted in an overestimation of the 
risk associated with caesarean delivery on neonatal mortality. An instrumental variable method 
(IVM) originating from the field of econometrics has been utilized in modern epidemiological 
research to reduce the influence of unmeasured selection bias. By accounting for measured, 
unmeasured, and unknown confounding variables, utilizing the IVM can serve as a more valid 
approach in determining intervention effects amongst patients in observational studies.  
OBJECTIVE: The purpose of this study is to compare the results from traditional multivariate 
methods and instrumental variable-adjusted analyses to determine if caesarean delivery increases 
the risk of early neonatal death in comparison to vaginal birth.  
MATERIALS AND METHODS: This is a retrospective cohort study which compares the 
outcome of early neonatal mortality between 20 completed weeks of gestation and 7 days post-
partum among women who delivered through a caesarean section and women who delivered 
vaginally. The cohort includes all in-hospital births during the fiscal years of April 1, 2006 - 
March 31, 2009 across Canada identified in the Discharge Abstract Database (DAD) from the 
Canadian Institute of Health Information (CIHI), excluding deliveries in Quebec. The effect of 
mode of delivery, being either caesarean or vaginal delivery, on early neonatal mortality was 
measured using a bivariate logistic regression, followed by a multivariate logistic regression and 
instrumental variable-adjusted analysis which controlled for 24 covariates.  
RESULTS: Multivariate logistic regression indicated that caesarean delivery significantly 
reduced the risk of early neonatal death in comparison to vaginal birth by 21% (Adjusted OR = 
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0.79, 95%CI = 0.66-0.93, p = 0.006). Instrumental variable-adjusted regression indicated a lack 
of association between mode of delivery and early neonatal mortality (ARD = -0.0053, 95%CI = 
-4.3x10-3-3.0x10-3, p = 0.781).  
CONCLUSION: In conclusion, the findings from the IVM analysis suggest that the risk of early 
neonatal mortality is not influenced by the mode of delivery. However, given the large 
discrepancy in risk estimates between analytic methods, health-system level recommendations 
towards altering local caesarean rates should be avoided until its impact on maternal and 
neonatal morbidities, hospital costs, and resulting factors are better understood. Future 
researchers should aim to answer these questions using similar analytic methods to help inform 
health-care policy makers and providers of the safety of caesarean deliveries.  
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Chapter One - Introduction 
1.1 Background 
 
 As defined by Statistics Canada, early neonatal death is known as the death of a child 
under one week of age, excluding stillbirths.1  In contrast to most developing nations, the 
incidence of early neonatal mortality in industrialized countries is typically low.2,3  In Canada, 
early neonatal death comprised 0.31% of all live births in 2009 and has remained fairly constant 
over the last several decades.2,3  The leading causes of early neonatal death in the developed 
nations include congenital and chromosomal abnormalities as well as complications related to 
low birth weight.4  Other factors, such as intrauterine hypoxia, birth asphyxia, and complications 
of labor and delivery, have also been cited as significant contributors to early neonatal mortality 
rates.4  While the majority of early neonatal deaths are due to genetic predispositions, identifying 
the preventable causes which can be modified through policy and practice change has become a 
primary focus in recent years.4,5  Of these, the safety of caesarean delivery has been identified as 
an area in need of further evaluation in response to increasing caesarean delivery rates and its 
unclear relationship with neonatal survival.6-21   
 As shown in Figure 1, Canada has witnessed a rise in the proportion of caesarean 
deliveries which extends far beyond the recommended range of 10-15% established by the 
World Health Organization (WHO).9,22  Driven primarily by a rise in the primary caesarean 
section rate, caesarean deliveries comprised 27.2% of all deliveries in 2012, an 8.5% increase 
since 1997.9,23  Several studies have suggested that increases in caesarean delivery rates can be 
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attributed to a higher incidence of risk factors during pregnancy, including multiple gestation, 
macrosomia, and older maternal age.23,24  It has also been proposed that temporal changes in 
obstetrical management, which include routine caesarean deliveries for breech presentations and 
women with a history of caesarean delivery,  may partly explain the observed trend.25  Yet, 
despite uniform increases in risk factors for caesarean delivery across the country, distinct 
regional trends in caesarean delivery rates persist.26  Among the provinces, the rate of caesarean 
sections in 2012 ranged from 21.4% in Manitoba to 32.0% in British Columbia, while the 
territories ranged from 11.3% in Nunavut to 25.0% in the Yukon.26  This suggests that 
differences in obstetrical management, whether it be regional, practice, or individually-based, are 
influencing an individual’s likelihood of receiving a caesarean delivery irrespective of their 
current health status.26  This theory has been supported by several studies which have 
demonstrated that significant increases in caesarean delivery rates remained after controlling for 
factors, such as a history of previous caesarean section, which may have explained the increasing 
trend.27   
 It is apparent that the decision to provide a caesarean section is far from black and white; 
a complex interaction of medical indications, litigation deterrents, and personal preferences are 
likely influencing a provider’s obstetrical management decisions and, in many cases, leading 
them to favor caesarean delivery over vaginal birth. Medico-legal factors have repeatedly shown 
to be predictive of an obstetrician’s clinical behavior.28-30   Fear of litigation for complications 
that arise during a vaginal delivery has partially contributed to an increase in caesarean delivery 
rates.28-30  It has been suggested that personal preference, which is largely dependent on 
experience and training, can also have a significant influence on decisions regarding mode of 
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delivery.31  One study found that a large portion of fourth year residents throughout the United 
States felt incompetent to perform obstetric forceps or vacuum deliveries and did not routinely 
incorporate them into their practice.31  Consequently, alternative procedures such as caesarean 
delivery may be chosen by obstetric residents and staff when faced with complicated labors. 
Other motivators, such as scheduling benefits, may bias providers to perform a caesarean 
delivery as it can take substantially less time to complete than a women in prolonged labor 
managed vaginally. A combination of these factors may help explain why providers have been 
found to perform a caesarean section for subjective indications in comparison to past years, 
highlighting the influence of non-medical factors in the decision making process.24  
 Irrespective of the conflicting evidence surrounding their safety, caesarean deliveries 
continue to become increasingly more common in the developed nations.32-41  To ensure that the 
incidence of early neonatal death is not affected by these increasing rates, it is important to 
determine whether the intervention itself poses any additional risk on neonatal survival when 
compared to vaginal birth. A better understanding of the association between caesarean delivery 
and early neonatal mortality is therefore warranted and crucial for health-care policy makers, 
providers, and expecting families.  
 
 
 
 
 
 
 4 
Figure 1: Temporal Trend in Total Caesarean Delivery Rates within Canada 
 
 
1.2 Literature Review 
 
1.21 Details of Search Strategy  
 Pubmed was initially used to identify articles which studied the association between 
caesarean delivery and early neonatal/neonatal/perinatal mortality. Articles were limited to those 
in English, associated with an abstract, and pertaining to humans. The initial search incorporated 
a MeSH term search of caesarean delivery in conjunction with vaginal delivery and early 
neonatal/neonatal/perinatal death or early neonatal/neonatal/perinatal mortality. Combining 
searches resulted in 1817 articles. Although Embase and Cochrane Library were also used to 
identify articles, they did not identify unique papers from that of Pubmed.  
1.22 Inclusion Criteria for Selection of Articles 
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 Articles were first selected based on the relevance of their title (n=85). These eighty-five 
articles were screened for applicability based on their abstract and a total of fourteen articles 
were reviewed.  
1.23 Review of the Literature 
 In an era where caesarean sections have become one of the most common inpatient 
surgeries, a visible rise in studies examining the relationship between caesarean delivery and 
maternal and neonatal health outcomes has been observed in the literature.42  While the effect of 
caesarean delivery in comparison to vaginal birth has been researched extensively with regard to 
maternal and neonatal morbidity, there are relatively few studies which have assessed its impact 
on neonatal mortality.7,8,10-21  Of those examining high-risk populations, a clear protective effect 
of caesarean delivery has been shown in the context of neonates delivered at the threshold of 
viability.13  Breech presentations managed by caesarean section have generally been shown to be 
protective across all birthweights, however some studies suggest that the protective effect is only 
present for specific birthweight categories.11,12,16  Only one study found that caesarean delivery 
imposed a significant risk on neonatal survival for breech presentations between twenty-four and 
thirty-four weeks.14  With respect to multiple gestations, Haest and his colleagues found no 
difference in perinatal mortality between twins born by caesarean section in comparison to 
vaginal birth.18  When stratified by fetal weight, one author found that those twins weighing less 
than 1000 grams together had an improved survival rate when delivered by caesarean section.17  
Lastly, while most studies assessing vaginal birth after caesarean (VBAC) versus repeat 
caesarean deliveries have focused on neonatal morbidity as their primary outcome, one study 
found that neonatal mortality was significantly increased for women undergoing a repeat 
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caesarean delivery as opposed to a VBAC.19  Many of these studies are limited by a small 
sample size and inadequate adjustment for important prognostic factors, likely impacting the 
validity of their results.  
 In studies which have not restricted their analyses to a specific sub-population, such as 
breech or preterm deliveries, caesarean section has consistently shown to increase the risk of 
neonatal mortality in comparison to vaginal birth.7,8,20,21  The World Health Organization 2005 
Global Survey on Maternal and Perinatal Health Research Group conducted a multi-center 
prospective study whereby one hundred and twenty three institutions were randomly assigned to 
take part in the study.21  Nurses and midwives working in the labor and postpartum wards from 
the enrolled institutions and trained staff reviewed medical records and collected information on 
the deliveries.21  Independent of measured confounding factors, the study found that elective 
caesarean delivery significantly increased the risk of neonatal death up to hospital discharge for 
fetuses in a cephalic presentation (Adjusted OR=1.66, 95%CI=1.26-2.20).21  Major limitations of 
the study revolve around its inability to standardize the diagnoses and indications for a caesarean 
delivery across the institutions involved.21  The authors also stress that a number of indications 
for a caesarean delivery which may have inflated risk estimates were not collected or adjusted 
for.21  Likewise, subjective diagnoses which may have been managed differently between 
institutions were also not captured during data collection.21  
 In 2009, De Luca and his colleagues conducted a prospective cohort study of obstetric 
and neonatal outcomes between women delivering by caesarean section and women delivering 
vaginally from a tertiary care hospital in Switzerland.20  They found that elective caesarean 
delivery significantly increased the risk of neonatal (intrapartum and predischarge) mortality by 
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109% relative to planned vaginal delivery, however the risk estimate was associated with a wide 
confidence interval (Adjusted OR= 2.09 , 95%CI= 1.07-4.09).20   
 In attempting to limit the study population to a low-risk group,  MacDorman and her 
colleagues retroactively analyzed a United States linked birth/infant death dataset and found that 
in term births with no known risk factors, caesarean delivery significantly increased the risk of 
neonatal death by roughly three times that of vaginal birth (Adjusted OR = 2.71, 95%CI = 2.43-
3.02).7  It has been argued that the study itself is methodologically flawed by including high-risk 
pregnancies and labors in the low-risk caesarean delivery group, potentially over-estimating the 
risk associated with caesarean delivery.43  In response, MacDorman and her colleagues examined 
a similar cohort using an intention-to-treat framework in hopes of accurately assigning deliveries 
to each study arm.8  An emergency caesarean section performed after a woman was in labor was 
combined with vaginal births to create a “planned vaginal delivery” group,  as this would 
indicate the intention to deliver vaginally.8  Conversely, the “planned caesarean delivery” group 
included only deliveries where a caesarean section was performed in the absence of labor.8  
Caesarean delivery remained a significant predictor of neonatal death in comparison to vaginal 
birth in using the intention-to-treat framework, however the adjusted odds ratio was attenuated 
by almost half (Adjusted OR = 1.69, 95% CI = 1.35-2.11).8  Although the intention-to-treat 
model was able to reduce the inflation of risk observed in the previous MacDorman study, it is 
likely that the risk associated with planned caesarean deliveries continues to be exaggerated due 
to a lack of adjustment for important unmeasured confounders.  
 Studies have shown that women receiving caesarean sections are more likely to have 
been affected by risk factors which are detrimental to their neonate’s survival, including older 
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maternal age, comorbities, preterm delivery, HIV positive status, multiple gestation, pre-
eclampsia, eclampsia, and previous caesarean section.44-48  Women receiving caesarean sections 
are also more likely to have experienced complications during labor and delivery, such as cord 
prolapse, placenta previa, abruption placenta, hemorrhage, premature rupture of membranes, and 
oligohydramnios.49-52  Likewise, the probability of neonates with low birth weights, macrosomia, 
and congenital anomalies in women delivered by caesarean section are much higher than those 
delivered vaginally, all of which have been shown to increase the odds of neonatal death.53-57  In 
addition to an array of medical indications for a caesarean delivery which predispose newborns 
to adverse outcomes, socioeconomic factors such as aboriginal identify and lower levels of both 
education and income are primarily seen in women delivering by caesarean section and 
independently reduce newborn survival.58,59  Hospital factors, such as high delivery volumes and 
levels of service, have also been associated with higher rates of both caesarean delivery and 
neonatal death due to the high-risk patients typically cared for at hospitals providing tertiary 
level care.60,61    
 Observational studies comparing neonatal death between caesarean and vaginal births 
have traditionally relied on standard statistical models to account for a large majority of the 
aforementioned confounding factors in their calculation of risk estimates. While standard 
statistical models are able to account for risk factors of early neonatal death which are captured 
in a hospital database, they are incapable of adjusting for hidden bias which may distort a 
researchers findings. Factors such as severity of comorbidities and patient frailty are rarely 
measured, yet would be inherently tied to a women’s likelihood of receiving a caesarean section 
and to the neonate’s survival. As a result, standard statistical methods used in observational 
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studies are more likely to produce biased findings since they are unable to account for 
unmeasured selection bias.  Evidence for this can be seen in randomized controlled trials (RCTs) 
which have refuted the results of observational studies, presumably due to inadequate adjustment 
for unmeasured confounding factors in their multivariate analyses.62  It is possible that the lack 
of adjustment for unmeasured selection bias has resulted in an overestimation of the risk 
associated with caesarean delivery on neonatal mortality and should be re-evaluated using more 
sophisticated analytic tools. 
1.3 Instrumental Variable Method (IVM) Approach   
 
 As a way to overcome the shortcomings inherent in observational studies, many 
researchers have begun to apply analytic methodologies which mimic some of the advantageous 
features of an RCT to observational datasets.62-65  One of these approaches, called the Propensity 
Score method, acts to evenly distribute measured baselines covariates between intervention and 
control groups by assigning a value to individuals who are likely to receive the intervention of 
interest based on a set of prognostic factors.66  By matching or stratifying these scores between 
the intervention and control groups, overt bias can be reduced between individuals with the same 
propensity score.62,66  However, analogous to multivariate models, the Propensity Score method 
does not account for unmeasured selection bias which may be associated with the intervention 
group.62  In response, an instrumental variable method (IVM) originating from the field of 
econometrics has been utilized to not only remove the effects of overt bias, but to also adjust for 
hidden bias in observational studies.62-65  When applied to observational datasets, this approach 
has yielded instrumental variable-adjusted estimates closely approximating those obtained from 
RCTs.62 
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 Unlike multivariate and Propensity Score methods, the IVM is able to equally distribute 
unmeasured confounding factors between intervention and control groups through the use of an 
instrumental variable (IV). Chosen by the investigative team, an IV must be identified which 
satisfies several conditions (Figure 2): First, it must strongly predict an individual’s likelihood of 
receiving the intervention.67  Secondly, it must not directly predict the outcome of interest, 
except through its association with the receipt of the intervention.67  Lastly, it must be an 
exogenous variable, so that it is not related to the outcome through measured or unmeasured 
paths.67  The IV, a proxy for randomization, functions to naturally randomize patients into 
groups which differ based on their likelihoods of receiving an intervention of interest.67  
Individuals are then compared based on their likelihoods of receiving an intervention rather than 
on the actual intervention they received, effectively balancing measured, unmeasured, and 
unknown confounding variables.67  This approach can be especially useful for observational 
studies assessing a surgical procedure, since patients who are candidates for a surgical 
intervention likely exhibit many unmeasured risk factors in comparison to their healthy 
counterparts which would inflate risk estimates. By accounting for unmeasured sources of bias, 
utilizing the IVM can serve as a more valid approach in determining intervention effects 
amongst patients in observational studies.  
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Figure 2: The Assumptions of the Instrumental Variable (IV) 
 
 
1.4 Purpose of Study 
 
 The research surrounding the influence of caesarean delivery on neonatal mortality in 
comparison to vaginal birth is limited and is likely influenced by unmeasured selection bias. The 
purpose of this study is to compare the results from traditional multivariate methods and IV-
adjusted analyses to determine if caesarean delivery increases the risk of early neonatal death in 
comparison to vaginal birth. Specifically, we will aim to address the following questions: 
Objective 1: In comparison to vaginal delivery, is caesarean delivery associated with an 
increased risk of early neonatal mortality in the Canadian obstetric population? 
Objective 2: Is the association between mode of delivery, including caesarean or vaginal 
delivery, and early neonatal mortality dependent on the statistical method used?  
1.5 Significance of Study 
 
1. The IV (Z) must strongly predict receipt of the intervention (X).67 
2. The IV (Z) must only be associated with the outcome (Y) through its direct association with the intervention (X).67 
3. The IV (Z) must not be associated with the outcome through measured or unmeasured (U) paths.67 
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 To our knowledge, this will be the first study to utilize the IVM approach when assessing 
the relationship between caesarean delivery and early neonatal mortality in comparison to 
vaginal birth. The conclusions drawn from IVM analyses apply only to the marginal population, 
i.e. those who would receive a caesarean delivery in one region but not in another.62  Due to the 
subjective nature of this definition, identifying a marginal individual in practice can be difficult. 
As a result, the conclusions drawn from instrumental variable analyses tend to be better suited 
for policy related questions related to health-system level factors as opposed to the clinical 
effectiveness for an individual patient.62  The conclusions generated from this study can thus 
guide health policy initiatives to target factors at the hospital level which are responsible for 
decisions regarding mode of delivery for the Canadian obstetric population.  
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Chapter Two - Methodology 
2.1 Study Design 
 
 This is a retrospective cohort study which compares the outcome of early neonatal 
mortality between women who delivered through a caesarean section with women who delivered 
vaginally. The cohort includes all in-hospital births during the fiscal years of April 1, 2006 - 
March 31, 2009 across Canada, excluding deliveries in Quebec. The exposed group (women who 
delivered by caesarean section) and the non-exposed group (women who delivered vaginally) 
were identified in the Discharge Abstract Database (DAD) from the Canadian Institute of Health 
Information (CIHI) using Canadian Classification of Health Interventions (CCI) codes. Linkage 
of the maternal data file and neonatal data file from CIHI allowed mother’s to be associated with 
their respective neonates. Newborns were followed between 20 completed weeks of gestation 
and 7 days post-partum in order for the incidence of early neonatal mortality to be compared 
between groups.  
2.2 Study Population 
 
Exclusion Criteria 
 To be consistent with other studies, newborns with a weight at delivery of less than 500 
grams were excluded because at the limit of viability, decisions regarding the mode of delivery 
would be highly variable.68,69  All stillbirths were removed from the study since they are likely 
unrelated to mode of delivery and largely dependent on non-intrapartum factors, such as genetic 
predispositions and pre-existing maternal comorbidities. Removing stillbirths, which comprise a 
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large proportion of early neonatal deaths, can thus help determine the effect of caesarean 
delivery on neonatal survival. Lastly, all deliveries in which additional instrumentation was used, 
in the form of obstetric forceps or vacuum, were excluded from the study population. Obstetric 
forceps and vacuum deliveries, in addition to deliveries in which both instruments were used, 
have been shown to increase the risk of neonatal morbidity in comparison to unassisted vaginal 
birth.70  Similarly, deliveries where either intervention was followed by a caesarean section have 
also been shown to increase the risk of adverse neonatal outcomes.71  Caesarean or vaginal 
deliveries simultaneously coded with obstetric forceps or vacuum extraction were therefore 
excluded from the study population to remove any potential adverse effect the instrumentation, 
as opposed to the caesarean section itself, had on the neonatal outcome.  
2.3 Data Sources 
 
 The primary data source used in this study was the Discharge Abstract Database (DAD), 
which includes hospital discharge records collected by the Canadian Institute of Health 
Information (CIHI).72  The DAD encompasses administrative, medical and demographic 
information from hospital in-patient discharges and day surgery interventions.72  With exception 
to Quebec, records are received directly from either acute care facilities, health/regional 
authorities, or ministries/departments of health across Canada.72   Unlike other regions of 
Canada, data from Quebec is collected in the Hospital Morbidity Database (HMDB), which we 
did not have access to.72  Comorbidities and complications are coded according to the 
International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, 
Canada - [ICD-10 CA], while procedures are coded according to the Canadian Classification of 
Health Interventions, Volume Three – [CCI]. In a data quality study using 2007-2008 DAD data 
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conducted by CIHI, it was found that the sensitivity for significant diagnoses relative to the gold 
standard of expert chart re-abstractions was 80.1% (95% CI 78.4% – 81.9%), showing a high 
degree of consistency for the completeness of reporting across all regions.73 
 Socioeconomic factors were obtained using 2006 Canadian Census Data aggregated at 
the Census Dissemination Area (CDA) level and mapped to patient postal codes. This study was 
approved by the Health Research Ethics Board (HREB) of Newfoundland and Labrador.  
2.4 Exposure Variable  
 
Exposed Group – Caesarean Delivery 
 Includes exclusive caesarean deliveries, excluding those in which additional 
instrumentation was used. The CCI codes used to identify exclusive caesarean deliveries can be 
seen in Appendix A.  
Non-exposed Group – Vaginal Delivery 
 Includes exclusive vaginal deliveries, excluding those in which additional 
instrumentation was used. The CCI codes used to identify exclusive vaginal deliveries can be 
seen in Appendix A.  
2.5 Dependent Variable 
 
Early Neonatal Mortality 
  Given that three quarters of all neonatal deaths occur during the first week of life, of 
which 25%-45% occur within the first day, the primary neonatal outcome of early neonatal 
mortality was defined as death between 20 completed weeks of gestation and 7 days post-
partum.74  This includes deaths that occurred in newborns who were discharged and then re-
 16 
admitted to hospital within 7 days of birth. We also decided to include deaths that occurred after 
7 days of age for newborns that were continuously hospitalized to help protect against bias due 
to hospitals that have the technological capabilities to keep infants alive on life support for 
greater than 7 days but who end up dying early in life. Stillbirths were excluded from the 
analysis. CIHI variables and ICD-10 codes were used to identify early neonatal deaths. The ICD-
10 codes used to identify early neonatal mortality can be found in Appendix B.  
2.6 Instrumental Variable (IV)  
 
Local Caesarean Delivery Rate  
 The local caesarean delivery rate was defined as the percentage of caesarean deliveries 
out of the total number of deliveries in the home hospital catchment area (HHCA).  In this study, 
the local caesarean delivery rate (measured as the caesarean delivery rate at an individual’s home 
hospital based on their place of residence) will serve as the instrumental variable for several 
reasons. Local caesarean delivery rates are highly variable across Canada and would therefore 
strongly predict an individual’s likelihood of receiving a caesarean section. To ensure that our 
instrumental variable is exogenous, i.e. not related to the outcome of early neonatal mortality 
through measured or unmeasured paths, we will use home hospital caesarean delivery rates as 
opposed to delivery hospital caesarean delivery rates. This is because most high risk 
pregnancies, which have an increased likelihood of caesarean section associated with them, are 
typically identified prenatally and referred to higher level hospitals for delivery. Consequently, 
delivery hospitals would likely show a strong association between caesarean section rates, risk 
factors, and the outcome of neonatal mortality and reduce the validity of the IV. A patient’s 
home hospital was determined using the hospital service area method.75  Using this method, a 
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postal code was attributed to a given hospital’s catchment area when a plurality of patients from 
the same postal code chose to obtain their care there. All (not just obstetrical) acute care hospital 
admissions during the study period were used to determine catchment areas. 
2.7 Statistical Analysis 
 
 Descriptive statistics, in the form of frequency (proportion) and mean + standard 
deviation, were conducted on categorical and continuous variables, respectively. The effect of 
mode of delivery, being either caesarean or vaginal delivery, on early neonatal mortality was 
measured using a bivariate logistic regression, followed by a multivariate logistic regression. 
 Upon completing these traditional analyses, an instrumental variable-adjusted analysis 
was conducted. Several models which support IV-adjusted analyses were considered, including  
a probit model, a model incorporating both ordinary least squares and logistic regressions, and a 
2-stage least squares (2SLS) model.76  IV-probit models are typically used in the setting of a 
dichotomous outcomes variable; however, when endogenous regressors are continuous, the use 
of IV-probit models are inappropriate.77  One author explains that another challenge with using 
IV-probit models is that their beta coefficients are difficult to interpret and often require varying 
scaling factors to produce a meaningful estimate.78  While theoretically ideal, risk estimates 
produced from models incorporating both an ordinary least squares regression and a secondary 
logistic regression for binary outcome variables are biased even when the IV is strong.79  Instead, 
we chose to perform the IV-adjusted analysis using a 2SLS model based on a linear 
distribution.76   In this model, the likelihood of receiving an intervention of interest is first 
assessed in a regression model as a function of measured covariates and the IV.76  Next, the 
intervention effect is estimated in a regression of the outcome on the predicted receipt of 
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intervention (as assessed in the first stage) while simultaneously adjusting for measured 
covariates.76  This step allows for groups to be compared based on their likelihood of receiving 
the intervention rather than actual intervention received.76  Although this study has a 
dichotomous outcome variable, the 2SLS model does not appear to affect risk estimates and may 
only marginally influence their standard errors.76  Similarly, little difference between point 
estimates and their precision has been shown between 2SLS models and models incorporating a 
logistic regression with an ordinary least squares regression for binary outcome variables.78,79 
Stukel and her colleagues used a similar approach when comparing catheterization with 
mortality at one and four years, implementing a 2SLS IV-adjusted analysis for exposure and 
outcome variables which were dichotomous in nature.62   
 To assess the effect of different levels of local caesarean delivery rates on early neonatal 
mortality, the IV was dummy coded into quintiles. These quintiles were entered into a 
multivariate logistic regression as the independent variable, using the lowest quintile as the 
reference category, to determine the impact of varying rates of local caesarean delivery on early 
neonatal mortality. While this constitutes an “implicit” use of the IVM and has been previously 
used in the literature, the majority of estimates drawn from this method can be hard to interpret 
individually.62  However, by specifically comparing the highest and lowest quintiles, we can 
better understand how regions experiencing high rates of caesarean sections compare to those 
experiencing low rates of caesarean sections with respect to the incidence of early neonatal 
death.   
 Both multivariate and instrumental variable-adjusted analyses adjusted for the following 
24 covariates: Gestational age at delivery, maternal age, HIV positive status, diabetes, 
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hypertension, multiple gestation, pre-eclampsia, eclampsia, previous caesarean section, neonatal 
sex, birth weight, congenital anomalies, cord prolapse, placenta previa, abruption placenta, 
hemorrhage, premature rupture of membranes, oligohydramnios, education level, income, 
aboriginal identity, level of hospital service, hospital delivery volume, and specialty of provider. 
The ICD-10 codes used to identify maternal risk factors, labor/delivery complications, and 
neonatal congenital anomalies can be found in Appendices C and D.  
 Hospital level of service was classified according to criteria published by the American 
Academy of Pediatrics and Canadian Pediatric Society with modifications for use with 
administrative data.80,81  Within this classification system, there are four levels of hospital 
service including Level 0, 1, 2, and 3 (Appendix E). Sub-classification of hospital service into 
Level 3b and Level 3c was dependent on a minimum of 5 records from a given hospital 
containing both the prerequisite procedure code and a compatible diagnosis code found in 
Appendix F. Socioeconomic (SES) factors were not directly available through the DAD, 
however we obtained this information through the 2006 Canadian Census Data aggregated at the 
Census Dissemination Area (CDA) level mapped to maternal postal codes. Income was defined 
by the Canadian Census as the mean “total household income in Canadian dollars from all 
sources minus federal, provincial and territorial income taxes paid for 2005 for individuals aged 
15 years and older, excluding institutionalized residents”.82  Aboriginal identity was defined by 
the Canadian Census as the “percentage of individuals who reported identifying with at least one 
Aboriginal group, that is, North American, Indian, Métis or Inuit, and/or those who reported 
being a Treaty Indian or a Registered Indian, as defined by the Indian Act of Canada, and/or 
those who reported they were members of an Indian band or First Nation”.82  Lastly, education 
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level was defined by the Canadian Census as the “percentage of individuals aged 15 years or 
older excluding institutional residents and employees who obtained at least a high school 
education, including both diplomas and degrees”.82 
 We used categorical variables to control for maternal age, delivery gestational age, and 
neonatal weight since they were shown to produce a better fit in the statistical models (i.e. 
multivariate logistic model of early neonatal death which adjusted for 398 delivery hospitals 
clusters) than transforming the variables and incorporating them as continuous variables. This 
was determined by referring to the Akaike information criterion (AIC) value, a measure of the 
quality of a statistical model. Subsequently, the interval division of a categorical variable 
resulting in the lowest Akaike information criterion (AIC) value, indicating a higher quality 
statistical model, was incorporated in the statistical analyses. Maternal age, measured in years, 
was categorized into 8 categories as follows: <= 14, 15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 
45-59, >=60 using the age range 25-29 as the reference group in the predictive model. Delivery 
gestational age, measured in weeks, was categorized into 9 categories as follows: <28, 28-29, 30-
31, 32-33, 34-35, 36-37, 38-39, 40-41, >41 using the delivery gestational age of 40-41 as the 
reference group in the predictive model. Lastly, neonatal weight, measured in grams, was 
categorized into 13 categories as follows: 500-749, 750-999, 1000-1249, 1250-1499, 1500-1999, 
2000-2499, 2500-2999, 3000-3499, 3500-3999, 4000-4499, 4500-4999, 5000-9000 using 3500-
4000 grams as the reference group in the predictive model. Conversely, the socioeconomic 
factors and delivery hospital volume were found to produce a better fit upon transformation as 
continuous variables than as categorical variables. Normality was assessed by graphing 
probability-probability (P-P) plots, which illustrate whether the observed data follows a linear or 
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non-linear distribution. Based on the results of the P-P plots for each of the variables analyzed, 
the following three transformations were performed and incorporated into the predictive models: 
(Education)3, (Aboriginal identity), and (Delivery hospital delivery volume).   
 The strength and validity of the instrumental variable were assessed through an F-statistic 
test and an analysis of the distribution of measured covariates across different levels of the IV. If 
the IV is strongly associated with the receipt of a caesarean delivery, the F statistic should be 
equal to or greater than 10 and the partial correlation coefficient between the IV and the receipt 
of a caesarean delivery will be large.76  Next, the IV, local caesarean delivery rates, was divided 
into quintiles to visualize the distribution of measured covariates across different levels of the 
IV. While it cannot be proven, it is assumed that if measured risk factors are evenly distributed 
across different levels of the IV, that unmeasured risk factors are similarly distributed. This 
would provide evidence that the IV we have chosen is exogenous. 
 The statistical software program STATA-13 was used for all analyses and a p-value less 
than 0.05 was considered to be statistically significant. Given that patients admitted to the same 
hospital may exhibit similar outcomes (thus violating the independence assumption), all analyses 
were adjusted for clustering at the delivery hospital using the “cluster” option in the IVREG2 
syntax.
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Chapter Three – Results 
3.1 Descriptive Statistics 
 
 The study cohort consisted of 844,410 mothers who delivered a total of 859,180 infants. 
Ninety-nine point four percent of the neonates were linked to a maternal record, representing 
842,278 deliveries. Of those deliveries, 0.05% were excluded due to inability to link to a single 
maternal record, 0.7% were excluded due to newborn weight <500 grams, 0.4% were excluded 
due to stillbirths, and 12.4% were excluded due to the use of forceps or vacuum during the 
delivery. After these exclusions, the study population included 728,235 unique deliveries. 
Covariate data was missing for 1.7% of deliveries. After removal of missing data, 715,615 
deliveries remained for the final analyses. All analyses adjusted for clustering in 398 hospitals.  
 Out of the 728,235 births included in this study, 29% (n = 211,226) were delivered by 
caesarean section, 71% (n = 517,009) were delivered vaginally, and early neonatal mortality 
occurred in 0.26% of cases (n = 1,907). All characteristics of the study population by mode of 
delivery can be seen in Table 1.  
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Table 1 - Characteristics of the Study Population based on Mode of Delivery 
 
 Caesarean Delivery Vaginal Delivery 
 (n=211,226) (n=517,009) 
 
Maternal Risk Factors 
  
GA at Delivery mean weeks + SD  38.3 + 2.6 39.0 + 2.3 
Age mean years + SD 30.5 + 5.6 28.8 + 5.6 
HIV positive status n (%)   211 (0.10) 231 (0.04) 
Type 1 Diabetes Mellitus n (%)   1,117 (0.53)   613 (0.12) 
Type 2 Diabetes Mellitus n (%)   1,139 (0.54) 960 (0.19) 
Gestational Diabetes Mellitus n (%)   13,572 (6.43) 19,402 (3.75) 
Unspecified Diabetes Mellitus n (%)   1,771 (0.84) 1,424 (0.28) 
Hypertension n (%)   19,417 (9.19) 24,014  (4.64) 
Twin n (%)   13,145 (6.22) 6,352 (1.23) 
Triplet n (%)   624  (0.30) 63 (0.01)  
Pre-Eclampsia n (%)     5,050  (2.39) 3,357 (0.65) 
Eclampsia n (%)   298 (0.14) 142 (0.03) 
Previous Caesarean Section n (%)   74,732 (35.38) 15,521 (3.00) 
   
Neonatal Risk Factors   
Birth Weight mean grams + SD 3,313 + 691 3,396 + 544 
Male n (%)   110,436 (52.28) 257,874 (49.88) 
Female n (%)   100,786 (47.71) 259,114 (50.12) 
Congenital Anomalies n (%)   8,876 (4.20) 13,647 (2.64) 
   
Labour/Delivery Complications   
Cord Prolapse n (%)   182 (0.09) 26 (0.01) 
Placenta Praevia n (%)   3,879 (1.84) 332  (0.06) 
Abruption Placenta n (%)   4,192 (1.98) 3,963 (0.77)  
Hemorrhage n (%)   1,743 (0.83) 2,024 (0.39) 
Premature Rupture n (%)   22,455 (10.63) 66,475 (12.86) 
Oligohydramnios n (%)   361 (0.17) 299 (0.06) 
   
CDA Socioeconomic Factors*   
High School Education† mean percentage + SD 84.3 + 12.4 83.1 + 13.8 
Income‡ mean Canadian dollars + SD 27,950 + 9,108 27,335 + 9,168 
Aboriginal IdentityՓ mean percentage + SD 56.0 + 17.4 8.14 + 21.1 
   
Delivery Hospital Factors   
Annual  
     Delivery Volume mean + SD 
 
2,546 + 1,601 
 
2,426 + 1,590 
     Obstetrician Delivery Volume mean + SD 224 + 157 192 + 171 
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Abbreviations: GA= Gestational Age; CDA= Census Dissemination Area  
* All variables measured by CDA using 2006 Canadian Census Data 
†    Data represents the average percentage of individuals aged 15 years or older excluding institutional residents 
and employees who obtained at least a high school education, including both diplomas and degrees 
‡    Data represents the average household income in Canadian dollars from all sources minus federal, provincial 
and territorial income taxes paid for 2005 for individuals aged 15 years and older, excluding institutionalized 
residents   
Փ  
Data represents the average percentage of individuals who reported identifying with at least one Aboriginal 
group, that is, North American, Indian, Métis or Inuit, and/or those who reported being a Treaty Indian or a 
Registered Indian, as defined by the Indian Act of Canada, and/or those who reported they were members of an 
Indian band or First Nation 
 
 
 
 
Hospital Level of Service  
    Level 0 n (%) 
 
49 (0.02) 
 
665 (0.13) 
    Level 1 n (%) 48,072 (22.76) 134,882 (26.09) 
    Level 2 n (%) 102,410 (48.48) 246,446 (47.67) 
    Level 3 n (%) 
Provider Type 
60,695 (28.73) 134,997 (26.11) 
    General Practitioner n (%) 9,861 (4.67) 168,886 (32.67) 
    Obstetrician n (%) 198,323 (93.89) 320,313 (61.96) 
    Midwife n (%) 47 (0.02) 25,159 (4.87) 
    Other n (%) 2,995 (1.42) 2,651 (0.51) 
 
 
 
 
 
 
 
 
 
 
 
3.2 Testing the Validity of the Instrumental Variable  
 
 The IV, local caesarean delivery rates, was highly variable across regions, ranging from 
0%-100%. In a multivariate logistic regression of the IV on the receipt of a caesarean delivery 
after adjusting for all 24 covariates, the adjusted r2 was 33.35%, the F statistic was 6552.53, and 
the p-value was <0.05. This indicates that the IV is strongly predictive of whether or not an 
individual received a caesarean section.  Further analysis of the validity of the IV shows that 
using local caesarean delivery rates as a proxy for randomization resulted in the majority of 
measured covariates to be equally distributed across different quintiles of the IV, with exception 
to previous caesarean section and education level (Table 2). Although we cannot prove that 
unmeasured covariates are equally distributed as well, it is fair to conclude that unmeasured 
covariates likely exhibit the same equal distribution across different levels of the IV. 
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Furthermore, the fact that early neonatal mortality did not show an increasing trend across 
quintiles of the IV gives evidence that the IV is not directly associated with the outcome, further 
strengthening the use of local caesarean delivery rates as our IV.   
 
Table 2 - The Distribution of Measured Covariates by Quintile of Local Caesarean 
Delivery Rates 
 
 Local Caesarean Section Rates by Quintile 
 Q1 Q2 Q3 Q4 Q5 
 (0-) (24.8-) (28.3-) (31.2-) (32.8-) 
 
Maternal Risk Factors 
     
GA at Delivery mean weeks 38.9 38.9 38.8 38.7 38.8 
Age mean years 27.8 29.0 29.4 30.1 30.1 
HIV positive status  % 0.06 0.05 0.07 0.07 0.05 
Type 1 Diabetes Mellitus % 0.25 0.23 0.24 0.25 0.23 
Type 2 Diabetes Mellitus % 0.42 0.29 0.24 0.24 0.25 
Gestational Diabetes Mellitus % 3.49 3.59 4.66 5.48 5.37 
Unspecified Diabetes Mellitus %  0.48 0.44 0.43 0.49 0.35 
Hypertension % 5.62 5.64 6.31 5.79 6.47 
Twin % 2.28 2.50 2.80 2.86 2.94 
Triplet % 0.07 0.09 0.09 0.13 0.09 
Pre-Eclampsia % 1.12 1.07 1.22 1.03 1.34 
Eclampsia % 0.08 0.06 0.05 0.05 0.06 
Previous Caesarean % 10.1 11.8 12.6 13.3 14.1 
      
Neonatal Risk Factors      
Birth Weight  mean grams 3,422 3,393 3,356 3,312 3,379 
Male % 50.5 50.6 50.4 50.8 50.6 
Female % 49.5 49.4 49.6 49.2 49.4 
Congenital Anomalies % 2.98 3.06 3.20 3.17 3.06 
      
Labour/Delivery Complications      
Cord Prolapse % 0.02 0.03 0.03 0.04 0.03 
Placenta Praevia % 0.41 0.55 0.55 0.70 0.68 
Abruption Placenta % 1.15 1.22 1.14 1.02 1.08 
Hemorrhage % 0.50 0.47 0.57 0.50 0.55 
Premature Rupture % 12.08 11.55 12.13 11.10 14.19 
Oligohydramnios % 0.07 0.14 0.13 0.07 0.04 
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Abbreviations: Q1-5= Quintile 1-5; GA= Gestational Age; CDA= Census Dissemination Area  
Note: Local caesarean delivery rates ranged from 0%-100% 
* All variables measured by CDA using 2006 Canadian Census Data 
†    Data represents the average percentage of individuals aged 15 years or older excluding institutional residents 
and employees who obtained at least a high school education, including both diplomas and degrees by quintile 
‡    Data represents the average household income in Canadian dollars from all sources minus federal, provincial 
and territorial income taxes paid for 2005 for individuals aged 15 years and older, excluding institutionalized 
residents by quintile 
Փ  
Data represents the average percentage of individuals who reported identifying with at least one Aboriginal 
group, that is, North American, Indian, Métis or Inuit, and/or those who reported being a Treaty Indian or a 
Registered Indian, as defined by the Indian Act of Canada, and/or those who reported they were members of an 
Indian band or First Nation by quintile  
 
 
 
 
CDA Socioeconomic Factors*      
High School Education† mean percentage 77.4 83.6 84.4 85.3 86.4 
Income‡ mean Canadian dollars 25,231 27,959 27,953 27,862 28,509 
Aboriginal IdentityՓ mean percentage  18.7 6.05 5.05 3.12 4.74 
      
Delivery Hospital  Factors      
Hospital Level of Service 
    Level 0 % 
 
0.28 
 
0.05 
 
0.10 
 
0.03 
 
0.04 
    Level 1 % 35.8 27.5 21.6 14.6 26.4 
    Level 2 % 29.7 52.0 55.5 60.3 42.0 
    Level 3 % 34.2 20.5 22.9 25.1 31.6 
Annual  
    Delivery Volume mean 
 
2,164 
 
2,147 
 
2,590 
 
2,959 
 
2,437 
    Obstetrician Delivery mean 
xxVolume mean 
221 
28.1 
200 
24.6 
193 
26.0 
240 
13.4 
151 
30.9 
Provider Type 
    General Practitioner % 
     
    Obstetrician % 65.7 71.2 71.0 83.4 64.7 
    Midwife % 3.83 4.03 2.72 2.85 3.88 
    Other % 2.39 0.25 0.28 0.40 0.56 
      
Neonatal Outcome      
Early Mortality % 0.31 0.24 0.25 0.27 0.24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3 Significance Testing 
 
 Caesarean delivery was not associated with an increased risk of early neonatal mortality 
compared with vaginal delivery in the bivariate logistic regression analysis. Multivariate logistic 
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Abbreviations: OR= Odds Ratio; ARD= Absolute Risk Difference  
*p<0.05 
Adjusted for 398 delivery hospital clusters 
“Other” provider type was omitted in the multivariate and IV-adjusted analyses due to collinearity 
 
 
 
regression indicated that after adjusting for all 24 covariates, caesarean delivery significantly 
reduced the odds of early neonatal death in comparison to vaginal birth by 21%. Instrumental 
variable-adjusted regression indicated a lack of association between mode of delivery and early 
neonatal mortality after adjusting for all 24 covariates. In comparison to the multivariate logistic 
regression, the instrumental variable-adjusted regression showed a lower goodness-of-fit (r2 = 
0.602 vs r2 = 0.345). All analyses were adjusted for 398 delivery hospitals clusters. These results 
can be seen in Table 3.  
 
 
Table 3 - The Effect of Caesarean Delivery on Early Neonatal Mortality in Comparison to 
Vaginal Birth 
 
 Risk 
Estimate 
95% CI p-value Measure 
of Risk 
 
Bivariate Logistic Regression  
 
1.10 
 
(0.93-1.31) 
 
0.283 
 
OR 
Multivariate Logistic Regression 0.79 (0.66-0.93) 0.006* OR 
Instrumental Variable Adjusted 
2 Stage Least Squares 
-0.00053 (-4.3x10-3-3.0x10-3) 0.781 ARD 
 
 
 
 
 
 In a multivariate logistic regression of the quintiles of the IV (local caesarean delivery 
rates) on early neonatal mortality which adjusted for all 24 covariates, the results indicated that 
the highest local caesarean delivery rates did not significantly increase the risk of early neonatal 
mortality in comparison with the lowest local caesarean delivery rates (Adjusted OR= 0.95, p= 
0.664, 95% CI= 0.76-1.19).
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Chapter Four - Discussion 
4.1 Main Findings  
 
 The protective effect of caesarean delivery has been demonstrated in the context of 
postpartum stress, urinary incontinence, symptomatic pelvic organ prolapse, and major and 
minor birth trauma in comparison with spontaneous vaginal births.32,33  Similarly, elective 
caesarean delivery has been shown to pose no additional risk on neonatal Apgar scores at 1 and 5 
minutes, neonatal infection and overall neonatal complications.34,35  To our knowledge, this is 
the first study to demonstrate a protective effect of caesarean delivery on early neonatal mortality 
when utilizing standard statistical methods. In contrast to the existing literature, this study 
indicates that caesarean delivery significantly decreases the risk of early neonatal death by 21% 
compared to vaginal delivery in the average obstetric population. There are several possible 
explanations for these findings. Earlier studies which have investigated the relationship between 
caesarean delivery and neonatal mortality analyzed obstetrical data between the mid 1990’s and 
early 2000’s, a time during which caesarean deliveries may have been performed in higher-risk 
individuals. To illustrate this point, one study found that increases in caesarean deliveries in 
Canada between 1994 and 2001 were largely attributed to an increase in the diagnosis of 
dystocia which is a somewhat subjective assessment of delayed progression of labor.24  The shift 
towards a more subjective approach in delivery management decisions may have led to a greater 
proportion of low-risk pregnancies being delivered by caesarean section. In addition, previous 
studies have typically defined neonatal mortality as death within 28 days of life and have 
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included stillbirths in this mortality count, likely resulting in a greater number of neonatal deaths 
being observed. Together, these factors may be responsible for the apparent discrepancy between 
risk estimates. 
  Variability between risk estimates from standard and IV-adjusted models have been 
previously observed in the invasive management of acute myocardial infarction and its impact 
on survival.62  In comparison to the multivariate analysis, this study found that the protective 
effect of caesarean delivery on early neonatal mortality was lost when applying the IVM, 
demonstrating that the observed association between caesarean delivery and early neonatal death 
is dependent on the statistical method used.  These findings suggest that the risk estimates 
obtained from the multivariate model are biased by unmeasured factors which are responsible for 
the perceived safety of caesarean sections. In a report awaiting publication, primary author Dr. 
Aubrey-Bassler proposes that the apparent protective effect of caesarean delivery on neonatal 
outcomes may be a result of a disproportionate number of obese women delivering vaginally, 
given the risk of surgical complications in this population is high.83,84  Similarly, it is possible 
that women who do not avail of prenatal services are less likely of being offered a caesarean 
section and thus at an increased odds of delivering vaginally. Both an increased maternal body 
mass index (BMI) and lack of prenatal care have consistently shown to increase the risk of 
adverse neonatal outcomes and may explain some of the variability observed between analytic 
models.83,85,86 
 Discrepancies between the risk estimates obtained from the multivariate and IV-adjusted 
models may also be partially explained by differences in the interpretation of the coefficients 
from each model and the population to which they generalize. For instance, in a multivariate 
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regression, the beta coefficient associated with the exposure variable is representative of the 
adjusted odds ratio, a relative measure of risk which generalizes to the entire population from 
which the sample was drawn.87  Conversely, the beta coefficient associated with the exposure 
variable in a 2SLS IV-adjusted regression depicts the adjusted absolute risk difference, an 
absolute measure of risk which generalizes to the “marginal population”.87  The marginal 
population is defined as the sub-population of individuals whose intervention status depend on 
the value of the IV.87  Using the IVM, the calculated intervention effect would therefore not 
apply to patients who either always or never undergo a caesarean delivery; it only applies to the 
marginal population of patients for which the mode of delivery might vary between hospitals.87,88  
The findings from the IV-adjusted model would not apply to women who would virtually always 
receive a caesarean section despite local caesarean delivery rates, and may include women with 
serious heart conditions who cannot labor well or women with complete placenta previa - 
similarly, the findings would not apply to first time mothers with no risk factors prenatally or in 
labor since they would virtually never receive a caesarean section despite local caesarean 
delivery rates. Instead, our findings would only extend to women with uncertain and highly 
subjective indication(s) for a caesarean section, such as women with comorbidities of varying 
severity or women experiencing dystocia.  
 Given the subjective definition of the “marginal population”, identifying a marginal 
patient in practice would be challenging and likely differ between maternity care providers. As a 
result, it has been suggested that conclusions drawn from the IVM are better suited for health-
system level recommendations rather than the clinical effectiveness for an individual patient.62 
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However, given the large discrepancy in risk estimates we observed between analytic methods, 
recommendations towards the provision of caesarean sections at a local level should be avoided 
until a higher powered IV-controlled study is conducted to determine the impact on maternal and 
neonatal outcomes, and other relevant factors such as length of stay and hospital costs. 
Compared with spontaneous vaginal deliveries, previous studies have found an increased risk of 
anesthetic complications, venous thromboembolism, hemorrhage, wound hematoma, 
endometriosis, peripartum blood transfusion, hysterectomy, major puerperal infection, and re-
hospitalization within 30 days postpartum in the context of planned caesarean sections.36-38  
Neonatal complications, such as persistent pulmonary hypertension, respiratory problems, low 
Apgar scores, transient tachypnea, and > 24 hour neonatal intensive care unit (NICU) admission 
have also been observed in neonates delivered by elective caesarean section compared with those 
delivered spontaneously.39-41  Furthermore, CIHI has estimated that in comparison to vaginal 
birth, caesarean delivery is associated with nearly twice the cost ($4,600 versus $2,700) and 
hospital length of stay (4 versus 2 days) in the Canadian population.89  Assuming that the 
existing evidence is also affected by unadjusted selection bias, future research should utilize the 
IVM to help health-care policy makers and providers establish well-evidenced recommendations 
towards the provision of caesarean sections. 
4.2 Limitations 
 
 The tests used to assess the strength and validity of the IV show that our use of local 
caesarean delivery rates satisfies the conditions of an IV fairly well. However, among increasing 
quintiles of the IV, there was a clear trend noted between local caesarean delivery rates and 
previous caesarean sections. Similarly, education level was associated with increasing levels of 
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the IV and was found to significantly predict early neonatal mortality in both multivariate and 
instrumental variable-adjusted models (Table 2). Considering the variability noted among these 
measured covariates, it is plausible that unmeasured covariates lack an equal distribution across 
levels of the IV as well. The presence of unmeasured covariates which significantly predict early 
neonatal mortality could have potentially decreased the validity of our IV and biased the results 
obtained from the IV-adjusted analysis.  
 In this study, both caesarean and vaginal deliveries simultaneously coded with forceps or 
vacuum-use were excluded. This was done to remove the negative impact that a forceps or 
vacuum intervention, rather than the caesarean or vaginal delivery itself, may have had on the 
delivery outcome. Thus, “failed” vaginal deliveries that went on to be delivered by a caesarean 
section were not captured in the analyses and may explain some of the discrepancy between the 
findings of this study and the previous literature. We also failed to adjust for women who have 
contributed more than one birth to the database over the three year period. Neonates born from 
the same mother are more likely to exhibit similar outcomes than those born from different 
mothers, a factor which may have led to a violation of the independence assumption and 
impacted the validity of our results.  
 The analyses conducted in this study have relied on the accuracy of in-hospital records in 
order to identify caesarean deliveries, which may be prone to coding errors, however in-hospital 
interventions were shown to have a high degree of accuracy when compared with a patient’s 
medical chart in a 2007-2008 Data Quality study by CIHI using the DAD (PPV = 94, 95%CI = 
91-98).73  Mortality may also be prone to similar coding errors. To decrease this possibility, we 
used both ICD-10 coding as well as CIHI variables to capture mortality. Although the DAD data 
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may technically be incomplete for early neonatal mortality (death before 7 days of age) because 
of deaths occurring after hospital discharge, it is highly likely that early neonatal deaths 
following hospital discharge and before 7 days of age would be extremely small in number and 
would be attributable to factors other than the quality of obstetrical care provided. Given privacy 
concerns, we were unable to obtain individual-level socioeconomic data. Instead, socioeconomic 
variables were aggregated by CDAs from the 2006 Canadian Census and it is uncertain whether 
generalizations of socioeconomic factors at the aggregated level extend to each individual.  
Despite these limitations, this study has yielded estimates which are less likely to be affected by 
unmeasured selection bias since the IV was highly predictive of the receipt of a caesarean 
delivery and was not directly associated with early neonatal mortality.   
4.3 Conclusion  
 
 In conclusion, the findings from the IVM analysis suggest that the risk of early neonatal 
mortality is not influenced by the mode of delivery. Given that the natural randomization of 
patients was based on local hospital-level factors and generalize only to the marginal population, 
the conclusions drawn from IVM analyses tend to be better suited for policy related questions 
directed at health-system level changes as opposed to the clinical effectiveness for an individual 
patient. Until a more in-depth understanding of local caesarean rates on maternal and neonatal 
morbidities, hospital costs, and resulting factors are established, health-system level 
recommendations towards altering local caesarean rates should be avoided. Consequently, future 
researchers should aim to answer these questions using similar analytic methods to help inform 
health-care policy makers and providers.
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Appendix A – CCI Codes used to Identify Exclusive Caesarean and 
Vaginal Deliveries 
 
CCI Code Description 
 
Exclusive Caesarean Section 
Delivery 
 
5MD60KE Caesarean hysterectomy 
5MD60JY Classical section (vertical incision in upper 
segment) 
5MD60KB Extraperitoneal section 
5MD60KG Inverted T incision 
5MD60KF Laparotomy (for abdominal pregnancy) 
5MD60AA Lower segment transverse incision 
5MD60KT Other type of Caesarean section NEC (e.g. 
vaginal, J incision) 
 
Exclusive Vaginal Delivery 
 
5MD50^^ Manually assisted vaginal delivery (vertex)  
Includes:  
- Crede maneuver  
- that with easy cord disentanglement (e.g. 
slipping cord over head of the fetus) 
- that with or without perineal massage 
- those classed as normal spontaneous vertex 
delivery, requiring minimal assistance from 
obstetrical personnel (e.g. Ritgen maneuver) 
5MD51^^ Unassisted spontaneous vaginal delivery 
Includes: 
- autonomous delivery where health 
professionals do not intervene or assist during 
the delivery (e.g. unattended delivery) 
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Appendix B – ICD-10 Codes used to Identify Early Neonatal Mortality 
 
ICD-10 Codes Description 
  
R96.0 Instantaneous death 
R96.1 Death occurring less than 24 hours from onset of symptoms, 
not otherwise explained 
R98 Unattended death 
R99 Other ill-defined and unspecified causes of mortality 
I461 Sudden cardiac death, so described 
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Appendix C – ICD-10 Codes used to Identify Maternal and Labor or 
Delivery Complications 
 
Condition ICD-10 Code Description 
   
Type 1 Diabetes 
Mellitus  
  
 E10.0 Type 1 diabetes mellitus with coma 
   
 E10.2 Type 1 diabetes mellitus with renal 
complications 
 E10.3 Type 1 diabetes mellitus with ophthalmic 
complications 
 E10.4 Type 1 diabetes mellitus with neurological 
complications 
 E10.5 Type 1 diabetes mellitus with circulatory 
complications 
 E10.6 Type 1 diabetes mellitus with other 
specified complications 
 E10.7 Type 1 diabetes mellitus with multiple 
complications 
 E10.8 Type 1 diabetes mellitus with unspecified 
complications 
 E10.9 Type 1 diabetes mellitus without (mention 
of) complication 
 O24.0 Pre-existing type 1 diabetes mellitus in 
pregnancy 
Type 2 Diabetes 
Mellitus 
  
 E11.0 Type 2 diabetes mellitus with coma 
 E11.2 Type 2 diabetes mellitus with kidney 
complications 
 E11.3 Type 2 diabetes mellitus with ophthalmic 
complications 
 E11.4 Type 2 diabetes mellitus with neurological 
complications 
 E11.5 Type 2 diabetes mellitus with circulatory 
complications 
 E11.6 Type 2 diabetes mellitus with other 
specified complications 
 E11.7 Type 2 diabetes mellitus with multiple 
complications 
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 E11.8 Type 2 diabetes mellitus with unspecified 
complications 
 E11.9 Type 2 diabetes mellitus without (mention 
of) complications 
 O24.1 Pre-existing type 2 diabetes mellitus in 
pregnancy 
Gestational 
Diabetes Mellitus 
  
 O24.4 Diabetes mellitus arising in pregnancy, 
gestational 
 P70.0 Syndrome of infant of mother with 
gestational diabetes 
Unspecified 
Diabetes Mellitus  
  
   
 E13.0 Other specified diabetes mellitus with coma 
 E13.2 Other specified diabetes mellitus with 
kidney 
 E13.3 Other specified diabetes mellitus with 
ophthalmic complications 
 E13.3 Other specified diabetes mellitus with 
ophthalmic complications 
 E13.4 Other specified diabetes mellitus with 
neurological complications 
 E13.5 Other specified diabetes mellitus with 
circulatory complications 
 E13.6 Other specified diabetes mellitus with other 
specified complications 
 E13.7 Other specified diabetes mellitus with 
multiple complications 
 E13.8 Other specified diabetes mellitus with 
unspecified complications 
 E13.9 Other specified diabetes mellitus without 
(mention of) complication 
 E14.0 Unspecified diabetes mellitus with coma 
 E14.2 Unspecified diabetes mellitus with kidney 
complications 
 E14.3 Unspecified diabetes mellitus with 
ophthalmic complications 
 E14.4 Unspecified diabetes mellitus with 
neurological complications 
 E14.5 Unspecified diabetes mellitus with 
circulatory complications 
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 E14.6 Unspecified diabetes mellitus with other 
specified complications 
 E14.7 Unspecified diabetes mellitus with multiple 
complications 
 E14.8 Unspecified diabetes mellitus with 
unspecified complications 
 E14.9 Unspecified diabetes mellitus without 
(mention of) complication 
 N08.3 Glomerular disorders in diabetes mellitus 
(E10-E14† with common fourth character 
.2) 
 O24.3 Glomerular disorders in diabetes mellitus 
(E10-E14† with common fourth character 
.2) 
 G63.2 Diabetic polyneuropathy (E10-E14† with 
common fourth character .4) 
 H36.0 Diabetic retinopathy (E10-E14† with 
common fourth character .3) 
 P70.1 Syndrome of infant of a diabetic mother 
Hypertension   
 I10 Essential (primary) hypertension 
 I11.0 Hypertensive heart disease with 
(congestive) heart failure 
 I11.9 Hypertensive heart disease without 
(congestive) heart failure 
 I12.0 Hypertensive renal disease with renal 
failure 
 I12.9 Hypertensive renal disease without renal 
failure 
 I13.0 Hypertensive heart and renal disease with 
(congestive) heart failure 
 I13.1 Hypertensive heart and renal disease with 
renal failure 
 I13.2 Hypertensive heart and renal disease with 
both (congestive) heart failure and renal 
failure 
 I13.9 Hypertensive heart and renal disease, 
unspecified 
 I15.0 Renovascular hypertension 
 I15.1 Hypertension secondary to other renal 
disorders 
 I15.2 Hypertension secondary to endocrine 
disorders 
 I15.8 Other secondary hypertension 
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 I15.9 Secondary hypertension, unspecified 
 O10.0 Pre-existing essential hypertension 
complicating pregnancy, childbirth and the 
puerperium 
 O10.1 Pre-existing hypertensive heart disease 
complicating pregnancy, childbirth and the 
puerperium 
 O10.2 Pre-existing hypertensive renal disease 
complicating pregnancy, childbirth and the 
puerperium  
 O10.3 Pre-existing hypertensive heart and renal 
disease complicating pregnancy, childbirth 
and the puerperium 
 O10.4 Pre-existing secondary hypertension 
complicating pregnancy, childbirth and the 
puerperium 
 O10.9 Unspecified pre-existing hypertension 
complicating pregnancy, childbirth and the 
puerperium 
 O13 Gestational (pregnancy-induced) 
hypertension without significant proteinuria 
 O16 Unspecified maternal hypertension 
 P00.0 Fetus and newborn affected by maternal 
hypertensive disorders 
Pre-Eclampsia O14.0 Moderate pre-eclampsia 
 O14.1 Severe pre-eclampsia 
 O14.2 HELLP syndrome 
 O14.9 Pre-eclampsia, unspecified 
Twin or 
Unspecified 
Multiple 
  
 O30.0 Twin pregnancy 
 O30.8 Other multiple gestation 
 O31.1 Continuing pregnancy after spontaneous 
abortion of one fetus or more or selective 
fetal reduction 
 O31.2 Continuing pregnancy after intrauterine 
death of one fetus or more 
 O30.9 Multiple gestation, unspecified 
 O32.5 Maternal care for multiple gestation with 
malpresentation of one fetus or more 
 O66.1 Obstructed labour due to locked twins 
Triplet or Higher   
 O30.1 Triplet pregnancy 
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 O30.2 Quadruplet pregnancy 
Previous 
Caesarean Section 
  
 O34.2 Uterine scar due to previous Caesarean 
section 
 O75.7 Vaginal delivery following previous 
Caesarean section 
Eclampsia   
 O15.0 Eclampsia in pregnancy 
 O15.1 Eclampsia in labour 
 O15.2 Eclampsia in the puerperium 
 O15.9 Eclampsia, unspecified as to time period 
HIV Positive 
Status   
  
 B20.0 HIV disease resulting in mycobacterial 
infection 
 B20.1 HIV disease resulting in other bacterial 
infections 
 B20.2 HIV disease resulting in cytomegaloviral 
disease 
 B20.3 HIV disease resulting in other viral 
infections 
 B20.4 HIV disease resulting in candidiasis 
 B20.5 HIV disease resulting in other mycoses 
 B20.6 HIV disease resulting in Pneumocystis 
jirovecii pneumonia 
 B20.7 HIV disease resulting in multiple infections 
 B20.8 HIV disease resulting in other infectious 
and parasitic diseases 
 B20.9 HIV disease resulting in unspecified 
infectious or parasitic disease 
 B21.0 HIV disease resulting in Kaposi sarcoma 
 B21.1 HIV disease resulting in Burkitt lymphoma 
 B21.2 HIV disease resulting in other types of non-
Hodgkin lymphoma 
 B21.3 HIV disease resulting in other malignant 
neoplasms of lymphoid, haematopoietic and 
related tissue 
 B21.7 HIV disease resulting in multiple malignant 
neoplasms 
 B21.8 HIV disease resulting in other malignant 
neoplasms 
 B21.9 HIV disease resulting in unspecified 
malignant neoplasm 
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 B22.0 HIV disease resulting in encephalopathy 
 B22.1 HIV disease resulting in lymphoid 
interstitial pneumonitis 
 B22.2 HIV disease resulting in wasting syndrome 
 B22.7 HIV disease resulting in multiple diseases 
classified elsewhere 
 B23.0 Acute HIV infection syndrome 
 B23.1 HIV disease resulting in (persistent) 
generalized lymphadenopathy 
 B23.2 HIV disease resulting in haematological and 
immunological abnormalities, not elsewhere 
classified 
 B23.8 HIV disease resulting in other specified 
conditions 
 B24 Unspecified human immunodeficiency virus 
[HIV] disease 
 F024 Dementia in human immunodeficiency 
virus [HIV] disease (B22.0+) 
 O98.7 Human immunodeficiency [HIV] disease 
complicating pregnancy, childbirth and the 
puerperium 
 R75 Laboratory evidence of human 
immunodeficiency virus [HIV] 
 Z21 Asymptomatic human immunodeficiency 
virus [HIV] infection status 
Premature 
Rupture of 
Membranes 
  
 O42.0 Premature rupture of membranes, onset of 
labour within 24 hours 
 O42.1 Premature rupture of membranes, onset of 
labour after 24 hours 
 O42.2 Premature rupture of membranes, labour 
delayed by therapy 
 O42.9 Premature rupture of membranes, 
unspecified 
 P01.1 Fetus and newborn affected by premature 
rupture of membranes 
Hemorrhage   
 O20.0 Threatened abortion 
 O20.8 Other haemorrhage in early pregnancy 
 O20.0 Haemorrhage in early pregnancy, 
unspecified 
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 O46.0 Antepartum haemorrhage with coagulation 
defect 
 O46.8 Other antepartum haemorrhage 
 O46.9 Antepartum haemorrhage, unspecified 
 O67.0 Intrapartum haemorrhage with coagulation 
defect 
 O67.8 Other intrapartum haemorrhage 
 O67.9 Intrapartum haemorrhage, unspecified 
Cord Prolapse   
 O69.0 Labour and delivery complicated by 
prolapse of cord 
 P02.4  
Placenta Praevia   
 O44 Fetus and newborn affected by prolapsed 
cord 
 P02.0 Fetus and newborn affected by placenta 
praevia 
Abruption 
Placenta 
  
 O45.0 Premature separation of placenta with 
coagulation defect 
 O45.8 Other premature separation of placenta 
 O45.9 Premature separation of placenta, 
unspecified 
 P02.1  Fetus and newborn affected by other forms 
of placental separation and haemorrhage 
 
 
 50 
Appendix D – ICD-10 Codes used to Identify Neonatal Congenital 
Anomalies 
 
ICD-10 Code Congenital Anomaly 
 
Q00.0 
 
Anencephaly  
Q00.1 Craniorachischisis 
Q00.2 Iniencephaly 
Q01.0 Frontal encephalocele 
Q01.1 Nasofrontal encephalocele 
Q01.2 Occipital encephalocele 
Q01.8 Encephalocele of other sites 
Q01.9 Encephalocele, unspecified 
Q03.0 Malformations of aqueduct of Sylvius 
Q03.1  Atresia of foramina of Magendie and Luschka 
Q03.8 Other congenital hydrocephalus 
Q03.9 Congenital hydrocephalus, unspecified 
Q04.0 Congenital malformations of corpus callosum 
Q04.1 Arhinencephaly 
Q04.2 Holoprosencephaly 
Q04.3 Other reduction deformities of brain 
Q04.4 Septo-optic dysplasia 
Q04.5 Megalencephaly 
Q04.6 Congenital cerebral cysts 
Q04.8 Other specified congenital malformations of brain 
Q04.9 Congenital malformation of brain, unspecified 
Q05.0 Cervical spina bifida with hydrocephalus 
Q05.1 Thoracic spina bifida with hydrocephalus 
Q05.2 Lumbar spina bifida with hydrocephalus 
Q05.3 Sacral spina bifida with hydrocephalus 
Q05.4 Unspecified spina bifida with hydrocephalus 
Q05.5 Cervical spina bifida without hydrocephalus 
Q05.6 Thoracic spina bifida without hydrocephalus 
Q05.7 Lumbar spina bifida without hydrocephalus 
Q05.8 Sacral spina bifida without hydrocephalus 
Q05.9 Spina bifida, unspecified 
Q06.0 Amyelia 
Q06.1 Hypoplasia and dysplasia of spinal cord 
Q06.2 Diastematomyelia 
Q06.3 Other congenital cauda equina malformations 
Q06.4 Hydromyelia 
Q06.8 Other specified congenital malformations of spinal cord 
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Q06.9 Congenital malformation of spinal cord, unspecified 
Q07.0 Arnold-Chiari syndrome 
Q07.8 Other specified congenital malformations of nervous system 
Q07.9 Congenital malformation of nervous system, unspecified 
Q10.0 Congenital ptosis 
Q10.6 Other congenital malformations of lacrimal apparatus 
Q10.7 Congenital malformation of orbit 
Q11.0 Cystic eyeball 
Q11.1 Other anophthalmos 
Q11.2 Microphthalmos 
Q11.3 Macrophthalmos 
Q12.0 Congenital cataract 
Q12.1 Congenital displaced lens 
Q12.2 Coloboma of lens 
Q12.3 Congenital aphakia 
Q12.4 Spherophakia 
Q12.8 Other congenital lens malformations 
Q12.9 Congenital lens malformation, unspecified 
Q13.0 Coloboma of iris 
Q13.1 Absence of iris 
Q13.2 Other congenital malformations of iris 
Q13.3 Congenital corneal opacity 
Q13.4 Other congenital corneal malformations 
Q13.8 Other congenital malformations of anterior segment of eye 
Q13.9 Congenital malformation of anterior segment of eye, 
unspecified 
Q14.0 Congenital malformation of vitreous humour 
Q14.1 Congenital malformation of retina 
Q14.2 Congenital malformation of optic disc 
Q14.3 Congenital malformation of choroid 
Q14.8 Other congenital malformations of posterior segment of eye 
Q14.9 Congenital malformation of posterior segment of eye, 
unspecified 
Q15.0 Congenital glaucoma 
Q15.8 Other specified congenital malformations of eye 
Q15.9 Congenital malformation of eye, unspecified 
Q16.0 Congenital absence of (ear) auricle 
Q16.1 Congenital absence, atresia and stricture of auditory canal 
(external) 
Q16.2 Absence of eustachian tube 
Q16.3 Congenital malformation of ear ossicles 
Q16.4 Other congenital malformations of middle ear 
Q16.5 Congenital malformation of inner ear 
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Q16.9 Congenital malformation of ear causing impairment of 
hearing, unspecified 
Q17.8 Other specified congenital malformations of ear 
Q18.3 Webbing of neck 
Q20.0 Common arterial trunk 
Q20.1 Double outlet right ventricle 
Q20.2 Double outlet left ventricle 
Q20.3 Discordant ventriculoarterial connection 
Q20.4 Double inlet ventricle 
Q20.5 Discordant atrioventricular connection 
Q20.6 Isomerism of atrial appendages 
Q20.8 Other congenital malformations of cardiac chambers and 
connections 
Q20.9 Congenital malformation of cardiac chambers and 
connections, unspecified 
Q21.0 Ventricular septal defect 
Q21.2 Atrioventricular septal defect 
Q21.3 Tetralogy of Fallot 
Q21.4 Aortopulmonary septal defect 
Q21.8 Other congenital malformations of cardiac septa 
Q21.9 Congenital malformation of cardiac septum, unspecified 
Q22.0 Pulmonary valve atresia 
Q22.0 Congenital pulmonary valve stenosis 
Q22.2 Congenital pulmonary valve insufficiency 
Q22.3 Other congenital malformations of pulmonary valve 
Q22.4 Congenital tricuspid stenosis 
Q22.5 Ebstein anomaly 
Q22.6 Hypoplastic right heart syndrome 
Q22.8 Other congenital malformations of tricuspid valve 
Q22.9 Congenital malformation of tricuspid valve, unspecified 
Q23.0 Congenital stenosis of aortic valve 
Q23.1 Congenital insufficiency of aortic valve 
Q23.2 Congenital mitral stenosis 
Q23.3 Congenital mitral insufficiency 
Q23.4 Hypoplastic left heart syndrome 
Q23.8 Other congenital malformations of aortic and mitral valves 
Q23.9 Congenital malformation of aortic and mitral valves, 
unspecified 
Q24.0 Dextrocardia 
Q24.1 Laevocardia 
Q24.2 Cor triatriatum 
Q24.3 Pulmonary infundibular stenosis 
Q24.4 Congenital subaortic stenosis 
Q24.5 Malformation of coronary vessels 
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Q24.6 Congenital heart block 
Q24.8 Other specified congenital malformations of heart 
Q24.9 Congenital malformation of heart, unspecified 
Q25.0 Patent ductus arteriosus 
Q25.1 Coarctation of aorta 
Q25.2 Atresia of aorta 
Q25.3 Stenosis of aorta 
Q25.4 Other congenital malformations of aorta 
Q25.5 Atresia of pulmonary artery 
Q25.6 Stenosis of pulmonary artery 
Q25.7 Other congenital malformations of pulmonary artery 
Q25.8 Other congenital malformations of great arteries 
Q25.9 Congenital malformation of great arteries, unspecified 
Q26.0 Congenital stenosis of vena cava 
Q26.1 Persistent left superior vena cava 
Q26.2 Total anomalous pulmonary venous connection 
Q26.3 Partial anomalous pulmonary venous connection 
Q26.4 Anomalous pulmonary venous connection, unspecified 
Q26.5 Anomalous portal venous connection 
Q26.6 Portal vein-hepatic artery fistula 
Q26.8 Other congenital malformations of great veins 
Q26.9 Congenital malformation of great vein, unspecified 
Q27.1 Congenital renal artery stenosis 
Q27.2 Other congenital malformations of renal artery 
Q27.3 Peripheral arteriovenous malformation 
Q27.4 Congenital phlebectasia 
Q27.8 Other specified congenital malformations of peripheral 
vascular system 
Q27.9 Congenital malformation of peripheral vascular system, 
unspecified 
Q28.0 Arteriovenous malformation of precerebral vessels 
Q28.1 Other malformations of precerebral vessels 
Q28.2 Arteriovenous malformation of cerebral vessels 
Q28.3 Other malformations of cerebral vessels 
Q28.8 Other specified congenital malformations of circulatory system 
Q28.9 Congenital malformation of circulatory system, unspecified 
Q30.0 Choanal atresia 
Q30.1 Agenesis and underdevelopment of nose 
Q30.2 Fissured, notched and cleft nose 
Q30.3 Congenital perforated nasal septum 
Q30.8 Other congenital malformations of nose 
Q30.9 Congenital malformation of nose, unspecified 
Q31.0 Web of larynx 
Q31.1 Congenital subglottic stenosis 
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Q31.2 Laryngeal hypoplasia 
Q31.3 Laryngocele 
Q31.8 Other congenital malformations of larynx 
Q31.9 Congenital malformation of larynx, unspecified 
Q32.1 Other congenital malformations of trachea 
Q32.2 Congenital bronchomalacia 
Q32.3 Congenital stenosis of bronchus 
Q32.4 Other congenital malformations of bronchus 
Q33.0 Congenital cystic lung 
Q33.2 Sequestration of lung 
Q33.3 Agenesis of lung 
Q33.4 Congenital bronchiectasis 
Q33.5 Ectopic tissue in lung 
Q33.6 Hypoplasia and dysplasia of lung 
Q33.8 Other congenital malformations of lung 
Q33.9 Congenital malformation of lung, unspecified 
Q34.0 Anomaly of pleura 
Q34.1 Congenital cyst of mediastinum 
Q34.8 Other specified congenital malformations of respiratory system 
Q34.9 Congenital malformation of respiratory system, unspecified 
Q35.1 Cleft hard palate 
Q35.3 Cleft soft palate 
Q35.5 Cleft hard palate with cleft soft palate 
Q35.7 Cleft uvula 
Q35.9 Cleft palate, unspecified 
Q36.0 Cleft lip, bilateral 
Q36.1 Cleft lip, median 
Q36.9 Cleft lip, unilateral 
Q37.0 Cleft hard palate with bilateral cleft lip 
Q37.1 Cleft hard palate with unilateral cleft lip 
Q37.2 Cleft soft palate with bilateral cleft lip 
Q37.3 Cleft soft palate with unilateral cleft lip 
Q37.4 Cleft hard and soft palate with bilateral cleft lip 
Q37.5 Cleft hard and soft palate with unilateral cleft lip 
Q37.8 Unspecified cleft palate with bilateral cleft lip 
Q37.9 Unspecified cleft palate with unilateral cleft lip 
Q38.0 Congenital malformations of lips, not elsewhere classified 
Q38.3 Other congenital malformations of tongue 
Q38.4 Congenital malformations of salivary glands and ducts 
Q38.6 Other congenital malformations of mouth 
Q38.7 Pharyngeal pouch 
Q38.8 Other congenital malformations of pharynx 
Q39.0 Atresia of oesophagus without fistula 
Q39.1 Atresia of oesophagus with tracheo-oesophageal fistula 
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Q39.2 Congenital tracheo-oesophageal fistula without atresia 
Q39.3 Congenital stenosis and stricture of oesophagus 
Q39.4 Oesophageal web 
39.5 Congenital dilatation of oesophagus 
Q39.6 Diverticulum of oesophagus 
Q39.8 Other congenital malformations of oesophagus 
Q39.9 Congenital malformation of oesophagus, unspecified 
Q40.2 Other specified congenital malformations of stomach 
Q40.3 Congenital malformation of stomach, unspecified 
Q40.8 Other specified congenital malformations of upper alimentary 
tract 
Q40.9 Congenital malformation of upper alimentary tract, 
unspecified 
Q41.0 Congenital absence, atresia and stenosis of duodenum 
Q41.1 Congenital absence, atresia and stenosis of jejunum 
Q41.2 Congenital absence, atresia and stenosis of ileum 
Q41.8 Congenital absence, atresia and stenosis of other specified 
parts of small intestine 
Q41.9 Congenital absence, atresia and stenosis of small intestine, part 
unspecified 
Q42.0 Congenital absence, atresia and stenosis of rectum with fistula 
Q42.1 Congenital absence, atresia and stenosis of rectum without 
fistula 
Q42.2 Congenital absence, atresia and stenosis of anus with fistula 
Q42.3 Congenital absence, atresia and stenosis of anus without fistula 
Q42.8 Congenital absence, atresia and stenosis of other parts of large 
intestine 
Q42.9 Congenital absence, atresia and stenosis of large intestine, part 
unspecified 
Q43.1 Hirschsprung disease 
Q43.2 Other congenital functional disorders of colon 
Q43.3 Congenital malformations of intestinal fixation 
Q43.4 Duplication of intestine 
Q43.5 Ectopic anus 
Q43.6 Congenital fistula of rectum and anus 
Q43.7 Persistent cloaca 
Q43.8 Other specified congenital malformations of intestine 
Q43.9 Congenital malformation of intestine, unspecified 
Q44.0 Agenesis, aplasia and hypoplasia of gallbladder 
Q44.1 Other congenital malformations of gallbladder 
Q44.2 Atresia of bile ducts 
Q44.3 Congenital stenosis and stricture of bile ducts 
Q44.4 Choledochal cyst 
Q44.5 Other congenital malformations of bile ducts 
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Q44.6 Cystic disease of liver 
Q44.7 Other congenital malformations of liver 
Q45.0 Agenesis, aplasia and hypoplasia of pancreas 
Q45.1 Annular pancreas 
Q45.2 Congenital pancreatic cyst 
Q45.3 Other congenital malformations of pancreas and pancreatic 
duct 
Q45.8 Other specified congenital malformations of digestive system 
Q45.9 Congenital malformation of digestive system, unspecified 
Q50.0 Congenital absence of ovary 
Q50.1 Developmental ovarian cyst 
Q50.2 Congenital torsion of ovary 
Q50.3 Other congenital malformations of ovary 
Q50.4 Embryonic cyst of fallopian tube 
Q50.5 Embryonic cyst of broad ligament 
Q50.6 Other congenital malformations of fallopian tube and broad 
ligament 
Q51.0 Agenesis and aplasia of uterus 
Q51.1 Doubling of uterus with doubling of cervix and vagina 
Q51.2 Other doubling of uterus 
Q51.3 Bicornate uterus 
Q51.4 Unicornate uterus 
Q51.5 Agenesis and aplasia of cervix 
Q51.6 Embryonic cyst of cervix 
Q51.7 Congenital fistulae between uterus and digestive and urinary 
tracts 
Q51.8 Other congenital malformations of uterus and cervix 
Q51.9 Congenital malformation of uterus and cervix, unspecified 
Q52.0 Congenital absence of vagina 
Q52.1 Doubling of vagina 
Q52.2 Congenital rectovaginal fistula 
Q52.4 Other congenital malformations of vagina 
Q52.6 Congenital malformation of clitoris 
Q52.7 Other congenital malformations of vulva 
Q52.8 Other specified congenital malformations of female genitalia 
Q52.9 Congenital malformation of female genitalia, unspecified 
Q53.1 Undescended testicle, unilateral 
Q53.2 Undescended testicle, bilateral 
Q53.9 Undescended testicle, unspecified 
Q54.0 Hypospadias, balanic 
Q54.1 Hypospadias, penile 
Q54.2 Hypospadias, penoscrotal 
Q54.3 Hypospadias, perineal 
Q54.4 Congenital chordee 
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Q54.8 Other hypospadias 
Q54.9 Hypospadias, unspecified 
Q55.0 Absence and aplasia of testis 
Q55.1 Hypoplasia of testis and scrotum 
Q55.3 Atresia of vas deferens 
Q55.4 Other congenital malformations of vas deferens, epididymis, 
seminal vesicles and prostate 
Q55.5 Congenital absence and aplasia of penis 
Q55.6 Other congenital malformations of penis 
Q55.8 Other specified congenital malformations of male genital 
organs 
Q55.9 Congenital malformation of male genital organ, unspecified 
Q56.0 Hermaphroditism, not elsewhere classified 
Q56.1 Male pseudohermaphroditism, not elsewhere classified 
Q56.2 Female pseudohermaphroditism, not elsewhere classified 
Q56.3 Pseudohermaphroditism, unspecified 
Q56.4 Indeterminate sex, unspecified 
Q60.0 Renal agenesis, unilateral 
Q60.1 Renal agenesis, bilateral 
Q60.2 Renal agenesis, unspecified 
Q60.3 Renal hypoplasia, unilateral 
Q60.4 Renal hypoplasia, bilateral 
Q60.5 Renal hypoplasia, unspecified 
Q60.6 Potter syndrome 
Q61.1 Polycystic kidney, autosomal recessive 
Q61.2 Polycystic kidney, autosomal dominant 
Q61.3 Polycystic kidney, unspecified 
Q61.4 Renal dysplasia 
Q61.5 Medullary cystic kidney 
Q61.8 Other cystic kidney diseases 
Q61.9 Cystic kidney disease, unspecified 
Q62.0 Congenital hydronephrosis 
Q62.1 Atresia and stenosis of ureter 
Q62.2 Congenital megaloureter 
Q62.3 Other obstructive defects of renal pelvis and ureter 
Q62.4 Agenesis of ureter 
Q62.5 Duplication of ureter 
Q62.6 Malposition of ureter 
Q62.8 Other congenital malformations of ureter 
Q63.0 Accessory kidney 
Q63.1 Lobulated, fused and horseshoe kidney 
Q63.2 Ectopic kidney 
Q63.8 Other specified congenital malformations of kidney 
Q63.9 Congenital malformation of kidney, unspecified 
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Q64.0 Epispadias 
Q64.1 Exstrophy of urinary bladder 
Q64.2 Congenital posterior urethral valves 
Q64.3 Other atresia and stenosis of urethra and bladder neck 
Q64.4 Malformation of urachus 
Q64.5 Congenital absence of bladder and urethra 
Q64.6 Congenital diverticulum of bladder 
Q64.7 Other congenital malformations of bladder and urethra 
Q64.8 Other specified congenital malformations of urinary system 
Q64.9 Congenital malformation of urinary system, unspecified 
Q65.0 Congenital dislocation of hip, unilateral 
Q65.1 Congenital dislocation of hip, bilateral 
Q65.2 Congenital dislocation of hip, unspecified  
Q65.8 Other congenital deformities of hip 
Q65.9 Congenital deformity of hip, unspecified 
Q66.0 Talipes equinovarus 
Q66.1 Talipes calcaneovarus 
Q68.1 Congenital deformity of hand 
Q68.8 Other specified congenital musculoskeletal deformities 
Q69.0 Accessory finger(s) 
Q69.1 Accessory thumb(s) 
Q69.2 Accessory toe(s) 
Q69.9 Polydactyly, unspecified 
Q70.0 Fused fingers 
Q70.1 Webbed fingers 
Q70.2 Fused toes 
Q70.3 Webbed toes 
Q70.4 Polysyndactyly 
Q70.9 Syndactyly, unspecified 
Q71.0 Congenital complete absence of upper limb(s) 
Q71.1 Congenital absence of upper arm and forearm with hand 
present 
Q71.2 Congenital absence of both forearm and hand 
Q71.3 Congenital absence of hand and finger(s) 
Q71.4 Longitudinal reduction defect of radius 
Q71.5 Longitudinal reduction defect of ulna 
Q71.6 Lobster-claw hand 
Q71.8 Other reduction defects of upper limb(s) 
Q71.9 Reduction defect of upper limb, unspecified 
Q72.0 Congenital complete absence of lower limb(s) 
Q72.1 Congenital absence of thigh and lower leg with foot present 
Q72.2 Congenital absence of both lower leg and foot 
Q72.3 Congenital absence of foot and toe(s) 
Q72.4 Longitudinal reduction defect of femur 
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Q72.5 Longitudinal reduction defect of tibia 
Q72.6 Longitudinal reduction defect of fibula 
Q72.7 Split foot 
Q72.8 Other reduction defects of lower limb(s) 
Q72.9 Reduction defect of lower limb, unspecified 
Q73.0 Congenital absence of unspecified limb(s) 
Q73.1 Phocomelia, unspecified limb(s) 
Q73.8 Other reduction defects of unspecified limb(s) 
Q74.1 Congenital malformation of knee 
Q74.2 Other congenital malformations of lower limb(s), including 
pelvic girdle 
Q74.3 Arthrogryposis multiplex congenital 
Q74.8 Other specified congenital malformations of limb(s) 
Q74.9 Unspecified congenital malformation of limb(s) 
Q75.0 Craniosynostosis 
Q75.1 Craniofacial dysostosis 
Q75.4 Mandibulofacial dysostosis 
Q75.5 Oculomandibular dysostosis 
Q75.8 Other specified congenital malformations of skull and face 
bones 
Q75.9 Congenital malformation of skull and face bones, unspecified 
Q76.1 Klippel-Feil syndrome 
Q76.2 Congenital spondylolisthesis 
Q76.3 Congenital scoliosis due to congenital bony malformation 
Q76.8 Other congenital malformations of bony thorax 
Q76.9 Congenital malformation of bony thorax, unspecified 
Q77.0 Achondrogenesis 
Q77.1 Thanatophoric short stature 
Q77.2 Short rib syndrome 
Q77.3 Chondrodysplasia punctata 
Q77.4 Achondroplasia 
Q77.5 Dystrophic dysplasia 
Q77.6 Chondroectodermal dysplasia 
Q77.7 Spondyloepiphyseal dysplasia 
Q77.8 Other osteochondrodysplasia with defects of growth of tubular 
bones and spine 
Q77.9 Osteochondrodysplasia with defects of growth of tubular 
bones and spine, unspecified 
Q78.0 Osteogenesis imperfecta 
Q78.1 Polyostotic fibrous dysplasia 
Q78.2 Osteopetrosis 
Q78.3 Progressive diaphyseal dysplasia 
Q78.4 Enchondromatosis 
Q78.5 Metaphyseal dysplasia 
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Q78.6 Multiple congenital exostoses 
Q78.8 Other specified osteochondrodysplasias 
Q78.9 Osteochondrodysplasia, unspecified 
Q79.0 Congenital diaphragmatic hernia 
Q79.1 Other congenital malformations of diaphragm 
Q79.2 Exomphalos 
Q79.3 Gastroschisis 
Q79.4 Prune belly syndrome 
Q79.5 Other congenital malformations of abdominal wall 
Q79.6 Ehlers-Danlos syndrome 
Q79.8 Other congenital malformations of musculoskeletal system 
Q79.9 Congenital malformation of musculoskeletal system, 
unspecified 
Q80.0 Ichthyosis vulgaris 
Q80.1 X-linked ichthyosis 
Q80.2 Lamellar ichthyosis 
Q80.3 Congenital bullous ichthyosiform erythroderma 
Q80.4 Harlequin fetus 
Q80.8 Other congenital ichthyosis 
Q80.9 Congenital ichthyosis, unspecified 
Q81.0 Epidermolysis bullosa simplex 
Q81.1 Epidermolysis bullosa letalis 
Q81.2 Epidermolysis bullosa dystrophica 
Q81.8 Other epidermolysis bullosa 
Q81.9 Epidermolysis bullosa, unspecified 
Q82.0 Hereditary lymphoedema 
Q82.1 Xeroderma pigmentosum 
Q82.2 Mastocytosis 
Q82.3 Incontinentia pigmenti 
Q82.4 Ectodermal dysplasia (anhidrotic) 
Q82.8 Other specified congenital malformations of skin 
Q82.9 Congenital malformation of skin, unspecified 
Q83.0 Congenital absence of breast with absent nipple 
Q83.1 Accessory breast 
Q83.2 Absent nipple 
Q83.8 Other congenital malformations of breast 
Q83.9 Congenital malformation of breast, unspecified 
Q84.0 Congenital alopecia 
Q84.1 Congenital morphological disturbances of hair, not elsewhere 
classified 
Q84.2 Other congenital malformations of hair 
Q84.3 Anonychia 
Q84.4 Congenital leukonychia 
Q84.6 Other congenital malformations of nails 
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Q84.8 Other specified congenital malformations of integument 
Q84.9 Congenital malformation of integument, unspecified 
Q85.0 Neurofibromatosis (nonmalignant) 
Q85.1 Tuberous sclerosis 
Q85.8 Other phakomatoses, not elsewhere classified 
Q85.9 Phakomatosis, unspecified 
Q86.0 Fetal alcohol syndrome (dysmorphic) 
Q86.1 Fetal hydantoin syndrome 
Q86.2 Dysmorphism due to warfarin 
Q86.8 Other congenital malformation syndromes due to known 
exogenous causes 
Q87.0 Congenital malformation syndromes predominantly affecting 
facial appearance 
Q87.1 Congenital malformation syndromes predominantly associated 
with short stature 
Q87.2 Congenital malformation syndromes predominantly involving 
limbs 
Q87.3 Congenital malformation syndromes involving early 
overgrowth 
Q87.4 Marfan syndrome 
Q87.5 Other congenital malformation syndromes with other skeletal 
changes 
Q87.8 Other specified congenital malformation syndromes, not 
elsewhere classified 
Q89.0 Congenital malformations of spleen 
Q89.1 Congenital malformations of adrenal gland 
Q89.2 Congenital malformations of other endocrine glands 
Q89.3 Situs inversus 
Q89.4 Conjoined twins 
Q89.7 Multiple congenital malformations, not elsewhere classified 
Q89.8 Other specified congenital malformations 
Q90.0 Trisomy 21, meiotic nondisjunction 
Q90.1 Trisomy 21, mosaicism (mitotic nondisjunction) 
Q90.2 Trisomy 21, translocation 
Q90.9 Down syndrome, unspecified 
Q91.0 Trisomy 18, meiotic nondisjunction 
Q91.1 Trisomy 18, mosaicism (mitotic nondisjunction) 
Q91.2 Trisomy 18, translocation 
Q91.3 Edwards syndrome, unspecified 
Q91.4 Trisomy 13, meiotic nondisjunction 
Q91.5 Trisomy 13, mosaicism (mitotic nondisjunction) 
Q91.6 Trisomy 13, translocation 
Q91.7 Patau syndrome, unspecified 
Q92.0 Whole chromosome trisomy, meiotic nondisjunction 
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Q92.1 Whole chromosome trisomy, mosaicism (mitotic 
nondisjunction) 
Q92.2 Major partial trisomy 
Q92.3 Minor partial trisomy 
Q92.4 Duplications seen only at prometaphase 
Q92.5 Duplications with other complex rearrangements 
Q92.6 Extra marker chromosomes 
Q92.7 Triploidy and polyploidy 
Q92.8 Other specified trisomies and partial trisomies of autosomes 
Q92.9 Trisomy and partial trisomy of autosomes, unspecified 
Q93.0 Whole chromosome monosomy, meiotic nondisjunction 
Q93.1 Whole chromosome monosomy, mosaicism (mitotic 
nondisjunction) 
Q93.2 Chromosome replaced with ring or dicentric 
Q93.3 Deletion of short arm of chromosome 4 
Q93.4 Deletion of short arm of chromosome 5 
Q93.5 Other deletions of part of a chromosome 
Q93.6 Deletions seen only at prometaphase 
Q93.7 Deletions with other complex rearrangements 
Q93.8 Other deletions from the autosomes 
Q93.9 Deletion from autosomes, unspecified 
Q95.2 Balanced autosomal rearrangement in abnormal individual 
Q95.3 Balanced sex/autosomal rearrangement in abnormal individual 
Q95.4 Individuals with marker heterochromatin 
Q95.5 Individuals with autosomal fragile site 
Q95.8 Other balanced rearrangements and structural markers 
Q95.9 Balanced rearrangement and structural marker, unspecified 
Q96.0 Karyotype 45,X 
Q96.1 Karyotype 46,X iso (Xq) 
Q96.2 Karyotype 46,X with abnormal sex chromosome, except iso 
(Xq) 
Q96.3 Mosaicism, 45,X/46,XX or XY 
Q96.4 Mosaicism, 45,X/other cell line(s) with abnormal sex 
chromosome 
Q96.8 Other variants of Turner syndrome 
Q96.9 Turner syndrome, unspecified 
Q97.0 Karyotype 47,XXX 
Q97.1 Female with more than three X chromosomes 
Q97.2 Mosaicism, lines with various numbers of X chromosomes 
Q97.3 Female with 46,XY karyotype 
Q97.8 Other specified sex chromosome abnormalities, female 
phenotype 
Q97.9 Sex chromosome abnormality, female phenotype, unspecified 
Q98.0 Klinefelter syndrome karyotype 47,XXY 
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 Note: If neonatal sex was identified as “other”, it was coded as a congenital anomaly  
Q98.1 Klinefelter syndrome, male with more than two X 
chromosomes 
Q98.2 Klinefelter syndrome, male with 46,XX karyotype 
Q98.3 Other male with 46,XX karyotype 
Q98.4 Klinefelter syndrome, unspecified 
Q98.5 Karyotype 47,XYY 
Q98.6 Male with structurally abnormal sex chromosome 
Q98.7 Male with sex chromosome mosaicism 
Q98.8 Other specified sex chromosome abnormalities, male 
phenotype 
Q98.9 Sex chromosome abnormality, male phenotype, unspecified 
Q99.0 Chimera 46,XX/46,XY 
Q99.1 46,XX true hermaphrodite 
Q99.2 Fragile X chromosome 
Q99.8 Other specified chromosome abnormalities 
Q99.9 Chromosomal abnormality, unspecified 
D21.5 Benign neoplasms of connective and other soft tissue of pelvis 
P35.0 Congenital rubella syndrome 
P35.1 Congenital cytomegalovirus infection 
P37.1 Congenital toxoplasmosis 
D82.1 Di George syndrome 
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Note: See Appendix F for the CCI and ICD-10 codes used to identify levels 3b and 3c.  
Appendix E – Definitions used to Identify Level of Hospital Service 
 
Hospital Level of Service  Definition 
 
Level 0 
  
<10% of deliveries 
from catchment area 
per year 
Level 1   >10% of deliveries 
from catchment area 
for neonates > 34 
weeks gestational age 
 a Usually vaginal 
deliveries only (<5 C-
sections/year) 
 
 b >5 C-sections per year 
by GP surgeon 
 c >5 C-sections per year 
by General Surgeon 
 d >5 C-sections per year 
by Obstetrician 
Level 2  An average of 4 or 
greater deliveries of 
neonates 32-34 weeks 
gestational age 
inclusive, with length 
of stay > 5 days per 
year. 
Level 3  Members of the 
Canadian Neonatal 
Network 
 a No major surgery 
 b Major surgery but no 
cardiac bypass or 
extra-corporeal 
membrane 
oxygenation 
 c Major cardiac surgery 
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Appendix F – ICD-10 Codes and CCI Codes used to Identify Level 3b 
and Level 3c Hospital Service 
 
CCI Code CCI Code Description ICD-10 ICD-10 Code 
Description 
 
For Level 3b 
1.SY.84.^^ Reconstruction, muscles of 
the chest and abdomen 
Q79.2 Exomphalos 
  Q79.3 Gastroschisis 
1.GJ.86.^^ Closure of fistula, trachea Q39.1 
 
Atresia of oesophagus 
with tracheo-
esophageal fistula 
  Q39.2 Congenital tracheo-
oesophageal fistula 
without atresia 
1.NA.87.^^ Excision partial, esophagus Q39.0 Atresia of oesophagus 
cout fistula 
1.NA.89.^^ Excision total, esophagus Q39.1 Atresia of oesophagus 
with  
1.NA.91.^^ Excision radical, espohagus  tracheo-esophageal 
fistula 
1.NA.84 Reconstruction, esophagus    
1.NK.80.^^ Repair, small intestine P77 Necrotizing 
enterocolitis 
1.NK.87.^^ Excision partial, small 
intestine 
A04.7 Enterocolitis due to C. 
difficile 
1.NM.80.^^ Repair, large intestine   
1.NM.87.^^ Excision partial, large 
intestine 
  
1.NM.91.^^ Excision radical, large 
intestine 
  
1.NQ.89.^^   Excision total, rectum     
1.NM.89.^^ Excision total, large 
intestine 
  
1.NM.91.^^ Excision radical, large 
intestine 
  
1.IM.51 Ligation of PDA Q25.0 Patent ductus 
arteriosus 
1.AC.52.ME-SJ 
1.AC.52.MF-SJ 
1.AC.52.MJ-SJ 
Drainage, ventricles of brain 
with shunt terminating in ^^  
– ^^ approach 
Q05.- Spina Bifida 
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Note: At least 5 records from a given hospital including a given CCI code and a compatible ICD-
10 code (compatible codes are grouped between horizontal gridlines in the table below) must be 
present to meet the criterion. 
1.AC.52.MP-SJ  Q03.- Congenital 
hydrocephalus 
1.AC.52.MQ-SJ    
1.AC.52.GN-SJ    
1.AC.52.GI-SJ    
1.AC.52.GK-SJ    
1.AC.52.GJ-SJ    
For Level 3c 
1.LZ.37.GP-GB  
1.LZ.37.LA-GB 
Cardiopulmonary bypass  
 
Q20.- Congenital 
malformations of 
cardiac chambers and 
connections 
1.LZ.37.GP-
QM 
Extracorporeal membrane 
oxygenator (ECMO) 
Q21.- Congenital 
malformations of 
cardiac septa 
  Q22.- Congenital 
malformations of 
pulmonary and 
tricuspid valves 
  Q23.- Congenital 
malformations of 
aortic and mitral 
valves 
  Q24.- Other congenital 
malformations of heart 
 
